Advocacy Webpage Graphics Narrow Teach It 

Addiction is a complex medical disease that has become a public health emergency throughout the US. ASAM advocates for policies that grow the addiction medicine workforce by integrating addiction medicine into medical school and residency curricula, supporting training programs, and incentivizing clinicians to work in programs and practices that specialize in the treatment of substance use disorder.




What is Addiction?

Addiction is a primary, chronic disease of brain reward, motivation, memory and related circuitry.

Click here to learn more




 
FOAM-header
 



Featured Public Policy Statements

_82007387_thinkstockphotos-515008423

E-Cigarettes

Learn more about ASAM's position on E-Cigarettes as a potential harm reduction strategy and for smoking cessation.

The Role of Recovery in Addiction Care

In ASAM’s definition, recovery from addiction is an active process of continual growth that addresses the biological, psychological, social and spiritual disturbances inherent in addiction.

Substance Use, Misuse, and Use Disorders During and Following Pregnancy, with an Emphasis on Opioids

Learn more about ASAM's policy recommendations on substance use, misuse, and SUDs during and following pregnancy.

Naloxone_2_(cropped)2

Use of Naloxone for the Prevention of Opioid Overdose Deaths

See ASAM's policy recommendations on Naloxone prescribing, training, and use.  







Strengthening the Substance Use Disorder Workforce Graphic




"When something is stigmatized nobody wants to bring it up,
so therefore people who need the help are less willing to come forward."

Corey Waller, MD, MS, FACEP, DFASAM
Member of ASAM's Legislative Advocacy Committee




Resources

11_PayForQuality - Copy


Learn more about the three medications currently approved by the FDA to treat opioid use disorder.

Updating map


How is the opioid overdose epidemic affecting your state?

cdc

Check out this CDC report and learn more about effective strategies to prevent opioid overdose in your community.

training

Learn more about the growing problem of controlled substance diversion from presentations made at the DEA Practitioner Diversion Awareness Conference

 
ecigarette2


Learn more about what the US Surgeon General has to say about e-cigarettes

 





ACCME 

Learn more about how ASAM is working to educate the next generation of addiction medicine professionals.





Related News

newspapers-3488857_1920B
  • December 19, 2018

    ASAM Submits Comments to FDA Regarding Strategies to Increase Naloxone Availability

    ASAM submitted comments to the Food and Drug Administration (FDA) in response to a request for comment ahead of a public advisory committee meeting regarding strategies to increase the availability of naloxone products intended for use in the community.
  • December 18, 2018

    US Surgeon General Proclaims E-Cigarette Use an Epidemic Among Youth

    US Surgeon General Jerome M. Adams issued a rare public health Advisory declaring the use of e-cigarettes an “epidemic among our nation’s young people.” The Advisory provides information to parents, educators, and health professionals on new types of e-cigarettes on the market, including JUUL, and the negative health consequences of youth use of these products.
  • December 6, 2018

    ASAM Unveils National Public Policy Statement on Substance Use Prevention

    ASAM has released a set of evidence-informed policy recommendations for preventing alcohol and drug-related problems in contemporary society. The policy recommendations were approved by the ASAM Board of Directors and have been endorsed by the American College of Preventive Medicine.